QA: Emergent Biosolutions Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001367644_2022_Emergent_Biosolutions_Inc.pdf

Logs

warning Large missing amount for aggregate "Revenues" added to remainder. industry.us_generic {'missing_ratio': inf, 'aggregate_val': 1792700000, 'exp_sum': 0, 'exp_to_value': {'remainder_Revenues': 0}}
warning Large missing amount for aggregate "Revenues" added to remainder. industry.us_generic {'missing_ratio': 227.75510204081633, 'aggregate_val': 1120900000, 'exp_sum': 4900000, 'exp_to_value': {'remainder_Revenues': 4900000}}
warning Large missing amount for aggregate "Expenses" added to remainder. industry.us_generic {'missing_ratio': 0.9887743114475916, 'aggregate_val': 1523600000, 'exp_sum': 766100000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 348400000, 'ResearchAndDevelopmentExpense': 234000000, 'remainder_Expenses': 183700000}}

Graph

Absolute values for 0001367644, Emergent Biosolutions Inc

  xvar xval
0 AssetsCurrent 1,272,100,000
1 IntangibleAssetsNetIncludingGoodwill 829,500,000
2 PropertyPlantAndEquipmentNet 800,100,000
3 remainder_Assets 57,300,000
4 LiabilitiesCurrent 373,800,000
5 LiabilitiesNoncurrent 866,800,000
6 remainder_Liabilities 99,400,000
7 CostOfGoodsAndServicesSold 21,006,528
8 SellingGeneralAndAdministrativeExpense 364,115,212
9 ResearchAndDevelopmentExpense 233,986,464
10 remainder_Expenses 4,809,737,231
11 remainder_Revenues 2,121,480,598
12 remainder_NetIncome -38,932,771
13 remainder_ComprehensiveNetIncome 3,540,483
  yvar yval
0 Assets 2,959,000,000
1 Liabilities 1,340,000,000
2 Expenses 5,428,845,435
3 Revenues 2,121,480,598
4 StockholdersEquity 1,619,000,000
5 NetIncome -3,346,297,608
6 ComprehensiveNetIncome -3,344,527,366
7 BaseVar 5,945,899,644
8 EconomicCapitalRatiobeforeLimitedLiability 0.0860
9 EconomicCapitalRatio 1.50

Edgar->Model Mapping

Feature Distribution

Change over Time